Use access key #2 to skip to page content.
$29.38 0.81 (2.84%)
7/23/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

3

Avatar carwasher1 (55.14) Submitted: 8/24/06 3:46 AM : Outperform Start Price: $44.74 AMLN Score: -32.89

This company has no where to go but up, albiet slowly. It has a diabetes drug that also helps loose weight. With diabetes and obesity on the rise world wide and Doctors just gaining info on their new drug, it would seem a true winner for all.

Report this Post Replies: 1 | Reply

Avatar PGH1037 (< 20) Submitted: 2/07/07 10:36 PM

Recs: 0 | Rec This

Diabetes will be an excellent business but what will really launch this company into the startosphere will be its weight loss pill. <<<< are you kidding me "you mean I can lose weight by taking a pill and not by exercising and sweating !"

THis company will bury Weight Watchers, Nutri Sys. and any others out there.

Report this Post Reply

Featured Broker Partners